ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,061.82
-1.20%
US Tech 100
17,265.60
0.13%
Dow Jones
37,735.11
0.00%
Brent Oil
89.265
-0.68%
Bitcoin
63,098.90
-0.48%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vivoryon Therapeut (VVY) Quote

Vivoryon Therapeut

Vivoryon Therapeut (VVY)

EU
0.476
-0.004
( -0.83% )
Updated: 07:44:59
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.476
Bid
0.4765
Ask
0.4795
Volume
73,429
0.476 Day's Range 0.4995
0.476 52 Week Range 19.56
Market Cap
-
Previous Close
0.48
Open
0.4995
Last Trade
1000
@
0.476
Last Trade Time
07:39:14
Financial Volume
-
VWAP
-
Average Volume (3m)
624,399
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Vivoryon Therapeut

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
1970
Vivoryon Therapeut is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker VVY. The last closing price for Vivoryon Therapeut was 0.48 €. Over the last year, Vivoryon Therapeut shares have traded in a share price range of 0.476 € to 19.56 €.

Vivoryon Therapeut currently has 0 shares outstanding.

VVY Latest News

More News

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024

Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024 Vivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and...

7 hours ago
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Announces Changes to Board Composition

Vivoryon Therapeutics N.V. Announces Changes to Board Composition Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon...

March 15 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease

Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease   Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of...

March 04 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024

Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Vivoryon Therapeutics N.V. to Host Investor Meetings in January 2024 Halle (Saale) / Munich, Germany, January 8, 2024 –...

January 08 2024
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress

Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and Highlights Operational Progress Vivoryon Therapeutics N.V. Reports Third Quarter 2023 Financial Results and...

December 06 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023

Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational Progress on December 6, 2023 Vivoryon Therapeutics N.V. to Report Q3 2023 Financial Results and Operational...

November 28 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference

Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conference Halle (Saale) / Munich, Germany, November 7, 2023 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7...

November 07 2023
GlobeNewswire Inc.

Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision

Vivoryon Therapeutics N.V. Provides Comprehensive Progress Report for Ongoing Varoglutamstat Clinical Program Following R&D Event and VIVA-MIND DSMB Dose Decision Vivoryon Therapeutics...

October 26 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.049-9.333333333330.5250.5250.4761726620.49667061DE
4-0.077-13.92405063290.5530.5580.4761663840.52105033DE
12-7.374-93.93630573257.859.930.4766243991.31467132DE
26-11.024-95.860869565211.511.60.4763328962.21687206DE
52-13.564-96.609686609714.0419.560.4761945624.08803934DE
156-13.744-96.652601969114.2223.250.4761070977.53208828DE
260-5.114-91.48479427555.5923.250.476988557.72249772DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DYNTDynatronics Corp
$ 0.7129
(92.47%)
5.92M
DFLIDragonfly Energy Holdings Corporation
$ 0.7099
(57.76%)
4.57M
WISAWiSA Technologies Inc
$ 2.68
(53.14%)
3.65M
MCBCMacatawa Bank Corporation
$ 13.71
(38.07%)
29.93k
LXEOLexeo Therapeutics Inc
$ 14.95
(23.66%)
652
RVYLRYVYL Inc
$ 1.25
(-39.35%)
21.46k
ALPPAlpine 4 Holdings Inc
$ 0.5111
(-30.93%)
1
DRMADermata Therapeutics Inc
$ 0.22
(-26.72%)
946.14k
INOInovio Pharmaceuticals Inc New
$ 8.32
(-24.29%)
5.34k
AIHAesthetic Medical International Holdings Group Ltd
$ 0.3029
(-23.34%)
3
KXINKaixin Holdings
$ 0.18
(20.00%)
10.78M
DYNTDynatronics Corp
$ 0.7129
(92.47%)
5.92M
SPCBSuperCom Ltd
$ 0.4916
(22.78%)
5.85M
DFLIDragonfly Energy Holdings Corporation
$ 0.7099
(57.76%)
4.57M
WISAWiSA Technologies Inc
$ 2.68
(53.14%)
3.65M

Discussion

View Full Feed
Mt. Blanc Mt. Blanc 3 minutes ago
NVDA. AMD. Climbing the slick wall today. Maybe Intel too.

mb
AMD NVDA
berigud berigud 4 minutes ago
GD, you are losing money on every purchase you make. But at least you help pay the electric bill. Thanks


YTD Return
IVDN
-23.81%
S&P 500
6.12%
1-Year Return
IVDN
-30.43%
S&P 500
22.34%
3-Year Return
IVDN
RIGATONI RIGATONI 5 minutes ago
Good morning! ~Rig
vinnie1965 vinnie1965 6 minutes ago
Realistically , this letter needs to be followed up with lobbyists who will negotiate a deal. Nothing moves through Doe without an exchange of "favors" ...the business of dealing with the Federal Government.
TGLO
mfaphoto mfaphoto 6 minutes ago
Message board positive or negative posts. I really do not believe anything said here has any impact whatsoever on the price of the stock. We are a tiny group out of the entire investment community. Few people will trade on message board chatter. So, say what you will. It is like shouting into th
NSAV
Zadie420 Zadie420 6 minutes ago
What is it that he cannot talk about it? and by who?
NWBO
moorecj1976 moorecj1976 6 minutes ago
Gooooooood DILUTIVE REVERSE SPLITTING RNVA morning!!!!
RNVA
Nelson2 Nelson2 6 minutes ago
Wish you the best with your calls mate
I had tried in the past and failed miserably
Just hold about 18,000 shares at around
$5.50 cost basis
Hoping our day will come

GLTU
BB
GBR GBR 6 minutes ago
did you find something new
VERI
mahatmapaul mahatmapaul 7 minutes ago
The "Confessions of a Paid Basher" was written as a tongue-in-cheek joke.

It's some twenty years old, I think. The original cites the "paid basher"'s law firm as

There are three types of bashers here at Franklin, Andrews, Kramer & Edelstein:
F.A.K.E.
SPZI
LongBalls LongBalls 7 minutes ago
Well, for someone who doesn’t invest in this stock, it sure does rent free space in your head. You’re on here every day making negative comments, your time must not have any value. now that you’ve warned everybody there’s no need for you to post anymore. Thanks bye-bye now go trigger on another pag
CGAC
frrol frrol 8 minutes ago
The village idiot
AVXL
TOM611 TOM611 8 minutes ago
Go. XALL. Blastoff get ready get set.
XALL
DrAsd333 DrAsd333 8 minutes ago
So where is the run if news started coming out?
KEGS
TOM611 TOM611 9 minutes ago
Go XALL. More buying should be happening now there’s not like this in the OTC with this kind of revenue.
XALL
hotdawg hotdawg 9 minutes ago
Good morning yall
BLEG
peteypickem peteypickem 10 minutes ago
I got caught ???? 😂😂😂😂😂 I don’t follow anyone 😂😂😄😄… I can do this all by myself… are you telling me your mentoring traders ??? 🤣🤣🤣… some of you people on these boards are hilarious. 96% of you can’t pick
ILST

Your Recent History

EU
VVY
Vivoryon Therapeut
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved